Clinical Trials Browser

OTHER_GOV × Interventional × Thoracic × Clear all

NCT07442890 2026-03-02

A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron

Phase NA Not yet recruiting

Lung Neoplasms

NCT05875870 2026-02-17

Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer

Phase NA Recruiting

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT07401498 2026-02-10

LNDNSCLC-RUS

Phase NA Enrolling by invitation

Lymph Node Dissection

NCT07388225 2026-02-05

The Effect of Preoperative Education on Recovery of Thoracic Surgery Patients

Phase NA Completed

Lung Neoplasms

NCT06370416 2026-01-28

the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Phase 2 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT07320105 2026-01-06

Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07280559 2025-12-12

Evaluation of AI-assisted LDCT Screening in Lung Cancer

Phase NA Not yet recruiting

Lung Neoplasms

NCT05236946 2025-09-10

Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

Phase 3 Recruiting

Asymptomatic Brain Metastases

NCT05277844 2025-09-10

TARGET-01

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05278052 2025-09-10

TARGET-02

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07108816 2025-08-07

A Single-center, Phase II Clinical Trial Evaluating the Efficacy of Sacituzumab Tirumotecan in Combination With Tagitanlimab as Neoadjuvant Therapy for PD-L1-positive, Resectable Stage II to IIIB Non-small Cell Lung Cancer (NSCLC)

Phase 2 Not yet recruiting

Resectable Stage II-IIIB NSCLC

NCT06709859 2025-07-17

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07069270 2025-07-16

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06617936 2025-07-15

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Phase 2 Recruiting

Unresectable Non-small Cell Lung Cancer

NCT06971848 2025-07-11

ETCABIO

Phase NA Not yet recruiting

GastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT06232083 2025-07-09

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Phase 1 Recruiting

GastrointestinalGynecologicThoracic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT07050043 2025-07-03

LEDANG

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03093688 2025-07-02

Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor

Phase 1/2 Recruiting

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT07039994 2025-06-26

AIRPAL

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung

NCT02078700 2025-06-25

Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.

Phase 2 Completed

GastrointestinalOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT02405273 2025-06-11

PUREAIR

Phase NA Completed

Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT06971406 2025-05-14

FLAME-1

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06051136 2025-04-02

OVER-CRF

Phase NA Active not recruiting

Lung Neoplasms

NCT06643000 2025-03-06

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06796816 2025-01-28

BIVA-18

Phase NA Recruiting

Adenocarcinoma of Lung, Lung Neoplasms, Sarcopenia

NCT06793228 2025-01-27

Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

Phase 2 Not yet recruiting

SCLC, Extensive Stage

NCT06786312 2025-01-22

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06760676 2025-01-07

A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy

Phase 1 Not yet recruiting

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms

NCT06679712 2024-11-07

5ALA-TBPDT

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06249854 2024-10-01

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06614621 2024-09-26

A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06527898 2024-09-19

Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer

Phase 1/2 Recruiting

Small Cell Lung Carcinoma

NCT06531460 2024-08-01

Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection

Phase NA Recruiting

Infections, Lung Neoplasms

NCT05269485 2024-06-25

Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06454890 2024-06-12

Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06436885 2024-05-31

An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer

Phase EARLY_PHASE1 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05878028 2024-05-23

L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06406608 2024-05-09

Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06406673 2024-05-09

A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

Phase 2 Unknown

Extensive Small Cell Lung Cancer

NCT05805631 2024-05-01

Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

Phase 2 Unknown

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT05377658 2024-02-21

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06262555 2024-02-16

Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy for Peripheral Lung Cancer

Phase NA Unknown

Lung Neoplasms

NCT06236997 2024-02-01

Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT06208033 2024-01-17

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Phase EARLY_PHASE1 Unknown

EGFR Positive Non-small Cell Lung Cancer

NCT06188650 2024-01-03

The Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical Study

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06141070 2023-11-21

ANDROMEDA

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06136910 2023-11-18

Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer

Phase 1/2 Unknown

Untreated Advanced Non-small Cell Lung Cancer

NCT03446547 2023-11-14

ASTEROID

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04375267 2023-11-14

LuPARP

Phase 1 Unknown

EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors